Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

784.48 

14.13 1.8%

as of Apr 09 '21

52 Week Range:

488.00 826.81


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 17.46
20.09
29.69
28.48
28.09
36.68
47.61
44.15
54.85
66.91
78.66
growth rate 15.1% 47.8% -4.1% -1.4% 30.6% 29.8% -7.3% 24.2% 22.0% 17.6%
Earnings BIT 572.30
709.70
893.90
870.90
627.20
753.20
961.80
1,062.90
1,244.60
1,375.00
1,048.60
growth rate 24.0% 26.0% -2.6% -28.0% 20.1% 27.7% 10.5% 17.1% 10.5% -23.7%
Avg.PE 27.17
37.59
30.67
22.94
45.97
34.51
37.67
69.30
55.28
49.90
84.36
growth rate 38.4% -18.4% -25.2% 100.4% -24.9% 9.2% 84.0% -20.2% -9.7% 69.1%
ROA 18.18
18.16
18.44
16.76
10.59
13.28
12.92
10.78
16.58
15.69
10.15
growth rate -0.1% 1.5% -9.1% -36.8% 25.4% -2.7% -16.6% 53.8% -5.4% -35.3%
ROE 21.36
21.14
21.09
18.95
12.17
15.30
14.58
12.57
19.78
18.46
11.79
growth rate -1.0% -0.2% -10.2% -35.8% 25.7% -4.7% -13.8% 57.4% -6.7% -36.1%
ROIC 21.36
21.14
21.09
18.95
12.17
15.30
14.58
12.57
19.78
18.46
10.24
growth rate -1.0% -0.2% -10.2% -35.8% 25.7% -4.7% -13.8% 57.4% -6.7% -44.5%
Cur. Ratio 4.66
4.57
4.71
5.07
3.69
4.46
5.45
3.99
5.28
4.53
6.86
growth rate -1.9% 3.1% 7.6% -27.2% 20.9% 22.2% -26.8% 32.3% -14.2% 51.4%
Quick Ratio 4.23
4.14
4.22
4.47
3.09
3.97
5.00
3.51
4.56
3.75
6.11
growth rate -2.1% 1.9% 5.9% -30.9% 28.5% 25.9% -29.8% 29.9% -17.8% 62.9%
Leverage 1.17
1.16
1.13
1.13
1.17
1.14
1.12
1.22
1.17
1.18
1.15
growth rate -0.9% -2.6% 0.0% 3.5% -2.6% -1.8% 8.9% -4.1% 0.9% -2.5%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 246.80
304.10
379.60
311.00
320.90
410.40
460.00
549.80
733.50
708.30
726.60
growth rate 23.2% 24.8% -18.1% 3.2% 27.9% 12.1% 19.5% 33.4% -3.4% 2.6%
Acct.Payable 166.40
215.90
180.80
61.60
52.60
68.50
82.50
100.70
123.50
81.60
growth rate 29.8% -16.3% -65.9% -14.6% 30.2% 20.4% 22.1% 22.6% -33.9%
Cur.Assets 1,275.80
1,466.30
1,892.80
1,932.40
1,811.90
2,195.50
3,250.40
2,808.90
4,333.20
4,662.60
6,625.90
growth rate 14.9% 29.1% 2.1% -6.2% 21.2% 48.1% -13.6% 54.3% 7.6% 42.1%
Total Assets 2,390.40
3,063.10
4,059.20
3,950.30
3,959.40
4,907.30
6,486.90
5,776.80
7,846.70
9,733.20
11,168.90
growth rate 28.1% 32.5% -2.7% 0.2% 23.9% 32.2% -11.0% 35.8% 24.0% 14.8%
Cash 279.80
465.80
553.70
782.10
600.30
714.60
1,036.60
648.20
857.90
1,167.60
1,622.60
growth rate 66.5% 18.9% 41.3% -23.3% 19.0% 45.1% -37.5% 32.4% 36.1% 39.0%
Inventory 86.80
112.10
121.50
179.60
181.70
167.90
182.30
241.20
409.00
595.50
601.50
growth rate 29.2% 8.4% 47.8% 1.2% -7.6% 8.6% 32.3% 69.6% 45.6% 1.0%
Cur.Liabilities 273.80
320.60
401.60
380.90
501.20
491.90
596.50
662.80
820.60
1,030.20
965.20
growth rate 17.1% 25.3% -5.2% 31.6% -1.9% 21.3% 11.1% 23.8% 25.5% -6.3%
Liabilities 353.00
417.50
479.10
448.90
580.00
587.80
709.10
996.40
1,159.20
1,448.50
1,409.80
growth rate 18.3% 14.8% -6.3% 29.2% 1.3% 20.6% 40.5% 16.3% 25.0% -2.7%
LT Debt 0.00 0.00 0.00
growth rate
Equity 2,037.40
2,645.60
3,580.10
3,501.40
3,379.40
4,319.50
5,777.80
4,778.80
6,678.80
8,263.80
9,731.50
growth rate 29.9% 35.3% -2.2% -3.5% 27.8% 33.8% -17.3% 39.8% 23.7% 17.8%
Common Shares 121.00
120.00
123.00
120.00
113.00
114.00
118.00
116.00
118.00
120.00
120.00
growth rate -0.8% 2.5% -2.4% -5.8% 0.9% 3.5% -1.7% 1.7% 1.7% 0.0%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 96.00
82.90
114.20
104.60
105.60
81.00
53.90
190.70
187.40
425.60
341.50
growth rate -13.7% 37.8% -8.4% 1.0% -23.3% -33.5% 253.8% -1.7% 127.1% -19.8%
Cash Dividends 0.00 0.00 0.00
growth rate
Cash From OA 545.80
677.60
814.20
880.00
665.10
806.20
1,087.00
1,143.90
1,169.60
1,598.20
1,484.80
growth rate 24.2% 20.2% 8.1% -24.4% 21.2% 34.8% 5.2% 2.3% 36.7% -7.1%
FCF per Share 3.57
4.11
5.45
5.77
5.51
4.93
8.09
7.89
8.46
8.75
8.24
growth rate 15.1% 32.6% 5.9% -4.5% -10.5% 64.1% -2.5% 7.2% 3.4% -5.8%
Sale Purchase of Stock -71.20
25.00
-948.60
283.60
361.10
580.90
415.50
growth rate 100.0% -100.0% 100.0% 27.3% 60.9% -28.5%
FCF 432.00
595.00
672.00
775.00
560.00
690.00
989.00
953.00
982.00
1,172.00
1,143.00
growth rate 37.7% 12.9% 15.3% -27.7% 23.2% 43.3% -3.6% 3.0% 19.4% -2.5%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 1,413.00
1,757.30
2,178.80
2,265.10
2,131.70
2,367.40
2,706.50
3,138.20
3,724.20
4,478.50
4,358.40
growth rate 24.4% 24.0% 4.0% -5.9% 11.1% 14.3% 16.0% 18.7% 20.3% -2.7%
Op.Income 555.20
495.10
656.60
671.00
627.20
753.20
961.80
1,062.90
1,244.60
1,375.00
1,048.60
growth rate -10.8% 32.6% 2.2% -6.5% 20.1% 27.7% 10.5% 17.1% 10.5% -23.7%
IBT 572.30
709.70
893.90
870.90
549.00
758.50
985.30
1,104.80
1,279.50
1,502.20
1,207.00
growth rate 24.0% 26.0% -2.6% -37.0% 38.2% 29.9% 12.1% 15.8% 17.4% -19.7%
Net Income 381.80
495.10
656.60
671.00
418.80
588.80
738.30
670.90
1,127.90
1,379.30
1,060.60
growth rate 29.7% 32.6% 2.2% -37.6% 40.6% 25.4% -9.1% 68.1% 22.3% -23.1%
EPS 3.16
4.11
5.33
5.58
3.70
5.18
6.26
5.77
9.49
11.54
8.82
growth rate 30.1% 29.7% 4.7% -33.7% 40.0% 20.9% -7.8% 64.5% 21.6% -23.6%
Gross Profit 1,030.00
1,273.80
1,570.30
1,594.20
1,413.80
1,577.90
1,892.90
2,202.00
2,604.10
3,110.20
2,861.20
growth rate 23.7% 23.3% 1.5% -11.3% 11.6% 20.0% 16.3% 18.3% 19.4% -8.0%
R&D 116.00
140.20
170.00
167.70
178.00
197.40
239.60
328.60
418.10
557.30
595.10
growth rate 20.9% 21.3% -1.4% 6.1% 10.9% 21.4% 37.2% 27.2% 33.3% 6.8%

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT 397.60
283.00
80.60
270.40
414.60
growth rate -28.8% -71.5% 235.5% 53.3%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 708.30
600.50
580.60
657.30
726.60
growth rate -15.2% -3.3% 13.2% 10.5%
Acct.Payable 123.50
133.40
108.90
116.00
81.60
growth rate 8.0% -18.4% 6.5% -29.7%
Cur.Assets 4,662.60
4,691.50
5,899.00
6,300.30
6,625.90
growth rate 0.6% 25.7% 6.8% 5.2%
Total Assets 9,733.20
9,891.10
10,103.60
10,617.50
11,168.90
growth rate 1.6% 2.2% 5.1% 5.2%
Cash 1,167.60
1,223.80
2,035.60
1,370.60
1,622.60
growth rate 4.8% 66.3% -32.7% 18.4%
Inventory 595.50
620.30
645.50
662.90
601.50
growth rate 4.2% 4.1% 2.7% -9.3%
Cur.Liabilities 1,030.20
945.90
924.80
894.70
965.20
growth rate -8.2% -2.2% -3.3% 7.9%
Liabilities 1,448.50
1,360.60
1,337.20
1,330.80
1,409.80
growth rate -6.1% -1.7% -0.5% 5.9%
LT Debt
growth rate
Equity 8,263.80
8,506.70
8,740.50
9,257.80
9,731.50
growth rate 2.9% 2.8% 5.9% 5.1%
Common Shares 116.00
0.10
0.10
0.10
0.10
growth rate -99.9% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 142.00
105.20
110.00
64.40
61.90
growth rate -25.9% 4.6% -41.5% -3.9%
Cash Dividends
growth rate
Cash From OA 552.70
352.80
229.90
274.60
627.50
growth rate -36.2% -34.8% 19.4% 128.5%
Sale Purchase of Stock
growth rate
FCF 410.70
247.60
119.90
210.20
565.60
growth rate -39.7% -51.6% 75.3% 169.1%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 1,310.20
1,099.50
852.10
1,077.70
1,329.10
growth rate -16.1% -22.5% 26.5% 23.3%
Op.Income 397.60
283.00
80.60
270.40
414.60
growth rate -28.8% -71.5% 235.5% 53.3%
IBT 426.70
308.10
107.20
355.20
436.50
growth rate -27.8% -65.2% 231.3% 22.9%
Net Income 357.70
313.50
68.00
313.90
365.20
growth rate -12.4% -78.3% 361.6% 16.3%
EPS
growth rate
Gross Profit 896.00
738.20
502.90
724.30
895.80
growth rate -17.6% -31.9% 44.0% 23.7%
R&D 156.60
147.10
143.20
155.00
149.80
growth rate -6.1% -2.7% 8.2% -3.4%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (73.03)

YOY Growth Grade:

C (57.92)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 86.82 88.94 50.11
EPS / Growth 20.7% 8.82 9.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 17.8%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 9.1% 15.9% 15.9%
Future PE 18.28 56.21 56.21
Future EPS 21.15 38.41 38.41
Value Price
MOS %
95.57
-87.8%
533.67
-32.0%
533.67
-32.0%
MOS Price 47.78 266.84 266.84
IRT 24.39 17.50 17.50

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.